Search - tctmd.com

Displaying 1 - 20 of 1296

Sort: Relevancy | Date

News Industry News

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

March 30, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

L.A. McKeown

March 16, 2026

News Conference News CRT 2026

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

Michael O'Riordan

March 11, 2026

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

L.A. McKeown

March 04, 2026

Presentation THT 2026

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Presenter: Ryan J. Tedford

March 03, 2026

News Daily News

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

L.A. McKeown

February 04, 2026

News Daily News

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

L.A. McKeown

January 27, 2026

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Yael L. Maxwell

December 09, 2025

Presentation TCT 2025

Case in the Box– Venous– IVUS and Scaffold for DVT

Presenter: Erin Murphy

October 28, 2025

Presentation TCT 2025

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Presenter: Teresa L. Carman

October 28, 2025

Presentation TCT 2025

Insights into PAD Pathogenesis from LIFE-BTK Substudies

Presenter: Sahil A. Parikh

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Presenter: Laurie Mobley

October 27, 2025

Presentation TCT 2025

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

Presenter: Marc P. Bonaca

October 27, 2025

Presentation TCT 2025

CFA: Is it Still Surgery First?

Presenter: Matthew T. Menard

October 26, 2025

Presentation TCT 2025

Long Segment SFA Disease – Surgery vs. PTAB

Presenter: Ehrin J. Armstrong

October 26, 2025

Presentation TCT 2025

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Presenter: Nanchao Hong

October 26, 2025

Advertisement

SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD

What’s Going to Be Hot at ACC 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

CRT 2026: What to Expect in Washington, DC

Pulmonary Artery Denervation (PADN) Treatment in Patients with Pulmonary Hypertension Due to Left Heart Disease: Initial Results of the PreVail-PH2 Early Feasibility Study

Weight Loss Drugs Show Promise for Secondary Prevention in PAD

Certain Coronary Cases, Like STEMI, Tip Total Radiation Exposure Higher

JACC Debuts Data Digest on CV Health in the United States

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

TAVI Patients Seem to Pay No Penalty for Obstructive CAD

Case in the Box– Venous– IVUS and Scaffold for DVT

Use of PAT and Other Perfusion Techniques in PAD/CLTI

Insights into PAD Pathogenesis from LIFE-BTK Substudies

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Multi-societal “Get a Pulse on PAD” Campaign: What We’ve Learned and the Impact So Far

Emerging Therapies: The Role of GLP-1 Agonists and SGLT2 Inhibitors in PAD/CLTI Management. Impact on the Guidelines

CFA: Is it Still Surgery First?

Long Segment SFA Disease – Surgery vs. PTAB

TCT 1932: Targeted Drugs, PADN, and Transcatheter Closure for Atrial Septal Defect-associated Pulmonary Hypertension: Case Series

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content